Fosun Pharma and others establish a new partnership in Jinan with a capital contribution of 75.01 million
Fosun Pharma, through its investment arm Suzhou Junming Zhiyuan Venture Capital, has co-established a new investment partnership in Jinan with an initial capital of 75.01 million RMB. The partnership, named Jinan Xing Weilai Future Medical Investment Management Partnership, will focus on investment activities, management, and consulting services. This move indicates Fosun Pharma's continued strategic investment in the healthcare sector. AI